Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Cytosorbents (CTSO) Q4 2025 Earnings Transcriptfool.com
Cytosorbents (CTSO) Q4 2025 Earnings Transcript
Via The Motley Fool · March 26, 2026
The Private Credit Reckoning: US Default Rates Surge as 'Golden Age' Ends
As of late March 2026, the once-indomitable private credit market is facing its most significant challenge since its post-2008 inception. A sharp acceleration in defaults across the United States has sent shockwaves through the "shadow banking" sector, with several high-profile Business Development Companies (BDCs) forced to slash dividends and gate
Via MarketMinute · March 26, 2026
This Elite Wealth-Creating Machine Is a Screaming Bargain These Daysfool.com
Brookfield Corporation could generate robust returns for shareholders over the next five years.
Via The Motley Fool · March 26, 2026
Sector Split: Materials and Discretionary Lead S&P 500 Gains as Real Estate Lags
The S&P 500 Index climbed higher on Thursday, March 26, 2026, as investors rotated aggressively into cyclical and growth-oriented sectors. The broad-market index rose 0.54% to close at 6,591.90, buoyed by a significant drop in energy costs and signs of geopolitical de-escalation in the Middle East.
Via MarketMinute · March 26, 2026
Braze Defies ‘SaaSpocalypse’ as Shares Surge 19.87% on AI Breakthrough and Earnings Beat
In a dramatic defiance of the broader market volatility currently plagueing the enterprise software sector, Braze Inc. (NASDAQ: BRZE) saw its shares skyrocket by 19.87% on Wednesday, March 25, 2026. The stock climbed from $18.02 to close at $21.60, marking its strongest single-day performance in over two
Via MarketMinute · March 26, 2026
Total Stock Market ETFs: SCHB and VTI Offer Nearly Identical Market Exposurefool.com
Explore how subtle differences in holdings and structure could influence your choice between these two leading broad-market ETFs.
Via The Motley Fool · March 26, 2026
MarketMinute: Corcept Therapeutics (CORT) Surges 19.66% on Surprise FDA Approval and Oncology Breakthrough
The biotechnology sector witnessed a seismic shift on March 26, 2026, as shares of Corcept Therapeutics (NASDAQ: CORT) surged 19.66% in heavy trading. The rally, which added nearly $1 billion to the company’s market capitalization, was triggered by a "perfect storm" of positive regulatory developments and breakthrough clinical
Via MarketMinute · March 26, 2026
This Monthly Income ETF Yields 12%, and Every Canadian Should Take Notehttps://www.fool.ca/2026/03/26/this-monthly-income-etf-yields-12-and-every-canadian-should-take-note/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=277134dd-ac5e-42f3-8407-20d45596d366
HDIF is geared for monthly income, but it comes with complexities due to the use of leverage and covered calls.
Via The Motley Fool · March 26, 2026
Nvidia Just Reported a $1 Trillion Order Pipeline. Why Is the Stock Barely Moving? Here's What Investors Are Missing.fool.com
An already-high valuation and fears of potential headwinds aren't the only things holding back the chipmaker's stock.
Via The Motley Fool · March 26, 2026
Silicon Tsunami: The $200 Billion AI IPO Wave Reshapes Wall Street
The technology sector is currently witnessing its most significant capital infusion since the early days of the cloud revolution. As of March 2026, the "AI Class of 2026"—led by the massive public debuts and imminent listings of CoreWeave, Databricks, and Cerebras Systems—has fundamentally altered the risk-appetite landscape of
Via MarketMinute · March 26, 2026
Wave Life Sciences Shakes Biotech Sector with Breakthrough Obesity Data: A New Era for ‘Quality’ Weight Loss
The biotechnology landscape witnessed a defining moment on March 26, 2026, as Wave Life Sciences (Nasdaq: WVE) released highly anticipated interim Phase 1 data from its INLIGHT trial. The study, which evaluates WVE-007—an investigational RNA interference (RNAi) therapy targeting the INHBE gene—aims to revolutionize obesity treatment by focusing
Via MarketMinute · March 26, 2026
Why Micron Stock Keeps Going Downfool.com
Morgan Stanley explains why Micron stock is too cheap to ignore.
Via The Motley Fool · March 26, 2026
GameStop Stabilizing: What Comes Next for Investors?marketbeat.com
Via MarketBeat · March 26, 2026
Kodiak Sciences Surges 19% as Phase 3 GLOW2 Trial Delivers Vital Win for Diabetic Retinopathy Treatment
On March 26, 2026, Kodiak Sciences (Nasdaq: KOD) saw its shares ignite, surging 19% in heavy trading following the announcement of overwhelmingly positive topline results from its Phase 3 GLOW2 study. The trial, which evaluated the company's lead product candidate Zenkuda™ (tarcocimab tedromer) in patients with diabetic retinopathy (DR), not
Via MarketMinute · March 26, 2026
Fed’s ‘Hawkish Pause’ Rattles Markets as Energy Shocks and Sticky Inflation Cloud 2026 Rate Path
The Federal Reserve has officially entered a "wait-and-see" era that is increasingly testing the patience of Wall Street. Following the conclusion of the March 2026 Federal Open Market Committee (FOMC) meeting, the central bank opted to maintain the federal funds rate at a range of 3.50% to 3.75%
Via MarketMinute · March 26, 2026
The $1.5 Trillion Shockwave: How Middle East Turmoil is Eroding U.S. Household Wealth
As of March 26, 2026, the American consumer is facing a sudden and severe financial headwind. A new report from Pantheon Macroeconomics reveals that U.S. household wealth has plummeted by an estimated $1.5 trillion in the first quarter of 2026 alone. This massive evaporation of net worth is
Via MarketMinute · March 26, 2026
Energy Sector Ignites: Crude’s Ascent Propels Markets to New Highs
The U.S. financial markets witnessed a powerful rally today, March 26, 2026, as the energy sector surged to multi-year highs, effectively hauling the broader indices into positive territory. Driven by a volatile mix of geopolitical instability in the Middle East and tightening global inventories, crude oil prices remained firmly
Via MarketMinute · March 26, 2026
The AI Reckoning: Microsoft’s Multi-Trillion Dollar Infrastructure Gamble Faces Market Maturity
REDMOND, WA — March 26, 2026 — As the first quarter of 2026 draws to a close, Microsoft Corp. (NASDAQ: MSFT) finds itself at a pivotal crossroads in the "AI Era" it helped ignite three years ago. While the tech giant has successfully embedded artificial intelligence into every facet of its product
Via MarketMinute · March 26, 2026
Silicon Architect Ascendant: ARM Holdings Skyrockets 16% as "AGI CPU" Dominance Signals New Era for AI Hardware
CAMBRIDGE, UK and NEW YORK — Shares of ARM Holdings (NASDAQ: ARM) experienced a seismic 16.38% surge today, March 26, 2026, marking the stock’s most explosive single-day gain since its initial public offering. The rally, which added billions to the company’s market capitalization, was triggered by a "perfect
Via MarketMinute · March 26, 2026
The Super Micro Plunge: Deep Value Opportunity or Terminal Value Trap?
The high-octane world of artificial intelligence hardware was rocked this week as shares of Super Micro Computer, Inc. (Nasdaq: SMCI) plummeted over 30% in a single trading session, wiping out nearly $6 billion in market value. The collapse follows the unsealing of a federal indictment that has sent shockwaves through
Via MarketMinute · March 26, 2026
Nintendo (NTDOY) Shares Under Pressure as Reports Surface of Major Switch 2 Production Cuts
The honeymoon period for Nintendo Co., Ltd. (OTC: NTDOY) and its record-breaking successor console appears to have come to an abrupt end. Shares of the Kyoto-based gaming giant have plummeted more than 6% this week following bombshell reports that the company is slashing production orders for the Nintendo Switch 2
Via MarketMinute · March 26, 2026
The Light Engine of AI: A Deep Dive into Lumentum Holdings (LITE) and the 1.6T Revolution
Note: This report is written from the perspective of March 26, 2026. Introduction As of early 2026, the global technology landscape has been redefined by the "Optical Supercycle," a massive infrastructure build-out required to sustain the computational demands of generative AI. At the heart of this physical layer revolution sits Lumentum Holdings Inc. (NASDAQ: LITE), [...]
Via Finterra · March 26, 2026
The Trillion-Dollar Countdown: SpaceX Sets the Stage for a Historic 2026 IPO
As the global financial markets open on March 26, 2026, a singular narrative has eclipsed all other fiscal news: the imminent public debut of SpaceX (Space Exploration Technologies Corp.). Long whispered about as the "holy grail" of initial public offerings, recent reports indicate that the aerospace giant is preparing to
Via MarketMinute · March 26, 2026
The Survival Pivot: A Deep-Dive into Beyond Meat’s (BYND) 2026 Earnings Delay and Structural Transformation
As of March 26, 2026, the plant-based meat pioneer Beyond Meat (NASDAQ: BYND) finds itself at a critical juncture that may determine its very survival. Once the darling of Wall Street following its explosive 2019 IPO, the company is currently grappling with a crisis of confidence. The focal point of investor anxiety this week is [...]
Via Finterra · March 26, 2026
Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data
CAMBRIDGE, MA — March 26, 2026 — Shares of Sarepta Therapeutics (NASDAQ:SRPT) skyrocketed 34.98% in heavy trading today, marking the biotech giant's most explosive single-day gain in over two years. The rally follows the release of breakthrough Phase 1/2 clinical data for its next-generation siRNA candidates, a development that
Via MarketMinute · March 26, 2026